Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Donna L. Beeson, D.O.
Internal Medicine · BOISE, ID · NPI 1689630436
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 621 | 48 |
| Atorvastatin Calcium | Atorvastatin Calcium | 368 | 51 |
| Levothyroxine Sodium | Levothyroxine Sodium | 327 | 40 |
| Furosemide | Furosemide | 288 | 46 |
| Gabapentin | Gabapentin | 266 | 38 |
| Pantoprazole Sodium | Pantoprazole Sodium | 226 | 40 |
| Potassium Chloride | Potassium Chloride | 220 | 36 |
| Metoprolol Succinate | Metoprolol Succinate | 210 | 30 |
| Trazodone Hcl | Trazodone Hcl | 193 | 27 |
| Myrbetriq | Mirabegron | 188 | 13 |
| Lisinopril | Lisinopril | 187 | 30 |
| Sertraline Hcl | Sertraline Hcl | 187 | 25 |
| Baclofen | Baclofen | 153 | 16 |
| Farxiga | Dapagliflozin Propanediol | 153 | 15 |
| Tamsulosin Hcl | Tamsulosin Hcl | 148 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 146 | 16 |
| Metformin Hcl | Metformin Hcl | 133 | 22 |
| Losartan Potassium | Losartan Potassium | 120 | 17 |
| Warfarin Sodium | Warfarin Sodium | 118 | suppressed |
| Amlodipine Besylate | Amlodipine Besylate | 110 | 24 |
| Escitalopram Oxalate | Escitalopram Oxalate | 109 | 19 |
| Omeprazole | Omeprazole | 102 | 26 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 96 | 17 |
| Metoprolol Tartrate | Metoprolol Tartrate | 94 | 14 |
| Bumetanide | Bumetanide | 92 | 18 |
| Famotidine | Famotidine | 82 | 13 |
| Fluticasone Propionate | Fluticasone Propionate | 81 | 20 |
| Lactulose | Lactulose | 78 | suppressed |
| Mirtazapine | Mirtazapine | 75 | 11 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 73 | 11 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 68 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 62 | suppressed |
| Spironolactone | Spironolactone | 62 | 14 |
| Buspirone Hcl | Buspirone Hcl | 60 | suppressed |
| Finasteride | Finasteride | 59 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 59 | suppressed |
| Carvedilol | Carvedilol | 58 | 11 |
| Jardiance | Empagliflozin | 58 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 55 | 13 |
| Xarelto | Rivaroxaban | 55 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 54 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 53 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 52 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 52 | 13 |
| Bupropion Xl | Bupropion Hcl | 51 | suppressed |
| Latanoprost | Latanoprost | 50 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 50 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 50 | 13 |
| Acetic Acid | Acetic Acid | 48 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 47 | suppressed |
| Prednisone | Prednisone | 47 | suppressed |
| Pregabalin | Pregabalin | 47 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 46 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 44 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 43 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 43 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 41 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 40 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 40 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 37 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 36 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 36 | suppressed |
| Gemtesa | Vibegron | 35 | suppressed |
| Lorazepam | Lorazepam | 35 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 34 | suppressed |
| Ondansetron Odt | Ondansetron | 34 | 12 |
| Erythromycin | Erythromycin Base | 33 | suppressed |
| Simvastatin | Simvastatin | 33 | suppressed |
| Sucralfate | Sucralfate | 32 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 30 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 30 | 12 |
| Levetiracetam | Levetiracetam | 30 | suppressed |
| Nystop | Nystatin | 30 | 19 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 29 | suppressed |
| Clonazepam | Clonazepam | 29 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 29 | suppressed |
| Ozempic | Semaglutide | 29 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 20 |
| Clonidine Hcl | Clonidine Hcl | 28 | suppressed |
| Risperidone | Risperidone | 28 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 27 | 16 |
| Meloxicam | Meloxicam | 27 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 27 | 22 |
| Admelog Solostar | Insulin Lispro | 26 | suppressed |
| Aripiprazole | Aripiprazole | 26 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 26 | suppressed |
| Digoxin | Digoxin | 26 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 26 | suppressed |
| Celecoxib | Celecoxib | 24 | suppressed |
| Clotrimazole | Clotrimazole | 24 | 15 |
| Trulicity | Dulaglutide | 24 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 23 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 23 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 23 | suppressed |
| Rytary | Carbidopa/Levodopa | 23 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 23 | suppressed |
| Allopurinol | Allopurinol | 22 | suppressed |
| Fetzima | Levomilnacipran Hcl | 22 | suppressed |
| Methocarbamol | Methocarbamol | 22 | suppressed |
| Qtern | Dapagliflozin/Saxagliptin Hcl | 22 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 21 | suppressed |
| Nystatin | Nystatin | 21 | 13 |
| Pravastatin Sodium | Pravastatin Sodium | 21 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 21 | suppressed |
| Cephalexin | Cephalexin | 20 | 14 |
| Combigan | Brimonidine Tartrate/Timolol | 20 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 20 | suppressed |
| Premarin | Estrogens, Conjugated | 20 | suppressed |
| Cyclosporine | Cyclosporine | 19 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 19 | suppressed |
| Ketoconazole | Ketoconazole | 19 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 19 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 18 | suppressed |
| Silodosin | Silodosin | 18 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 17 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 17 | suppressed |
| Estradiol | Estradiol | 17 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 17 | suppressed |
| Memantine Hcl | Memantine Hcl | 17 | suppressed |
| Restasis | Cyclosporine | 17 | suppressed |
| Torsemide | Torsemide | 17 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 16 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 16 | suppressed |
| Testosterone | Testosterone | 16 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Aptiom | Eslicarbazepine Acetate | 15 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 15 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 15 | suppressed |
| Lovastatin | Lovastatin | 15 | suppressed |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 15 | suppressed |
| Carbamazepine Er | Carbamazepine | 14 | suppressed |
| Haloperidol | Haloperidol | 14 | suppressed |
| Levemir Flexpen | Insulin Detemir | 14 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 14 | suppressed |
| Olanzapine Odt | Olanzapine | 14 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 14 | suppressed |
| Ramelteon | Ramelteon | 14 | suppressed |
| Azathioprine | Azathioprine | 13 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 13 | 13 |
| Clozapine | Clozapine | 13 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Ibuprofen | Ibuprofen | 13 | suppressed |
| Lidocaine | Lidocaine | 13 | suppressed |
| Movantik | Naloxegol Oxalate | 13 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 13 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 13 | suppressed |
| Carbamazepine | Carbamazepine | 12 | suppressed |
| Cefdinir | Cefdinir | 12 | suppressed |
| Glipizide | Glipizide | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 12 | 11 |
| Lacosamide | Lacosamide | 12 | suppressed |
| Levofloxacin | Levofloxacin | 12 | suppressed |
| Mexiletine Hcl | Mexiletine Hcl | 12 | suppressed |
| Paroxetine Er | Paroxetine Hcl | 12 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 12 | suppressed |
| Riluzole | Riluzole | 12 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 12 | suppressed |
| Daptomycin | Daptomycin | 11 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 11 | suppressed |
| Febuxostat | Febuxostat | 11 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 11 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 11 | suppressed |
| Rybelsus | Semaglutide | 11 | suppressed |
| Sotalol | Sotalol Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error